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SUPPLEMENTAL METHODS 
 
Literature Search  
Papers were identified using the following PubMed search terms: 
“(Christianson[All Fields] OR Pitt-Hopkins[All Fields] OR ("angelman syndrome"[MeSH Terms] OR 
("angelman"[All Fields] AND "syndrome"[All Fields]) OR "angelman syndrome"[All Fields]) OR ("CDKL5 
deficiency disorder"[Supplementary Concept] OR "CDKL5 deficiency disorder"[All Fields] OR "cdkl5 deficiency 
disorder"[All Fields]) OR ("down syndrome"[MeSH Terms] OR ("down"[All Fields] AND "syndrome"[All Fields]) 
OR "down syndrome"[All Fields]) OR ("epilepsies, myoclonic"[MeSH Terms] OR ("epilepsies"[All Fields] AND 
"myoclonic"[All Fields]) OR "myoclonic epilepsies"[All Fields] OR ("dravet"[All Fields] AND "syndrome"[All 
Fields]) OR "dravet syndrome"[All Fields]) OR (FOXG1[All Fields] AND ("syndrome"[MeSH Terms] OR 
"syndrome"[All Fields])) OR ("fragile x syndrome"[MeSH Terms] OR "fragile x syndrome"[All Fields]) OR 
("Telomeric 22q13 Monosomy Syndrome"[Supplementary Concept] OR "Telomeric 22q13 Monosomy 
Syndrome"[All Fields] OR "phelan mcdermid syndrome"[All Fields]) OR ("prader-willi syndrome"[MeSH Terms] 
OR ("prader-willi"[All Fields] AND "syndrome"[All Fields]) OR "prader-willi syndrome"[All Fields] OR 
("prader"[All Fields] AND "willi"[All Fields] AND "syndrome"[All Fields]) OR "prader willi syndrome"[All Fields]) 
OR ("rett syndrome"[MeSH Terms] OR ("rett"[All Fields] AND "syndrome"[All Fields]) OR "rett syndrome"[All 
Fields]) OR (16p11.2[All Fields] AND ("dna copy number variations"[MeSH Terms] OR ("dna"[All Fields] AND 
"copy"[All Fields] AND "number"[All Fields] AND "variations"[All Fields]) OR "dna copy number variations"[All 
Fields] OR ("copy"[All Fields] AND "number"[All Fields] AND "variation"[All Fields]) OR "copy number 
variation"[All Fields])) OR ("tuberous sclerosis"[MeSH Terms] OR ("tuberous"[All Fields] AND "sclerosis"[All 
Fields]) OR "tuberous sclerosis"[All Fields] OR ("tuberous"[All Fields] AND "sclerosis"[All Fields] AND 
"complex"[All Fields]) OR "tuberous sclerosis complex"[All Fields]) OR ("williams syndrome"[MeSH Terms] OR 
("williams"[All Fields] AND "syndrome"[All Fields]) OR "williams syndrome"[All Fields] OR ("williams"[All Fields] 
AND "beuren"[All Fields] AND "syndrome"[All Fields]) OR "williams beuren syndrome"[All Fields])) AND 
("induced pluripotent stem cells"[MeSH Terms] OR ("induced"[All Fields] AND "pluripotent"[All Fields] AND 
"stem"[All Fields] AND "cells"[All Fields]) OR "induced pluripotent stem cells"[All Fields] OR "ipsc"[All Fields]) 
AND ("humans"[MeSH Terms] OR "humans"[All Fields] OR "human"[All Fields]) AND ((Journal Article[ptyp] OR 
Classical Article[ptyp] OR Letter[ptyp]) AND English[lang]) AND ("0001/01/01"[PDAT] : "2019/07/12"[PDAT]).”   
 
Scoring 
Papers that provided details regarding fibroblast plating density and passage number, and information related 
to iPSC selection and karyotyping received higher scores than those that did not. Likewise, papers that utilized 
isogenic controls, familial or sex matched/age matched controls received higher scores than papers that did 
not. Inclusion of patient demographic information (whether in the manuscript or a citation of a previously 
published case report) resulted in a higher score. Finally, the quality of the differentiation protocol was 
evaluated with a higher score assigned to papers that either: (1) fully outlined the experimental procedures 
used, or (2) cited a previously published methods paper with a step-by-step protocol. Publications that 
indicated differentiation was carried out as previously described by other publications with slight modifications 
received an intermediate score if modifications were clearly outlined and a lower score if:  (1) no modifications 
were outlined and/or no detailed experimental procedure was provided or (2) the citation referenced did not 
provide a detailed protocol and/or referred to yet another paper. For differentiation quality control, papers are 
scored for data provided on RNA marker expression, protein marker expression, and functional assay. See 
also Figure 1 and Supplemental Table S1. We did not include the number of lines or number of patients in 
scoring, because these parameters are often study-dependent, and we were not able to score in a quantitative 
and objective manner. However, these two parameters are indicated in the size (number of lines) and color 






Supplemental Figure 1. Analysis of 58 papers using iPSCs as experimental systems for IDDs. Research 
articles were evaluated based on the following three categories: (1) iPSC derivation and quality control, which 
encompass both a detailed protocol for iPSC derivation and a detailed description of iPSC clonal selection and 
quality control (QC) assays. (2) Experimental design and background information, including a description of 
experimental controls and demographic information about the patients from whom iPSCs were derived. (3) 
Neural differentiation and quality control, including the differentiation protocol outlined, RNA and protein marker 
expression, and description of neuronal functional activity. (A) Overall score distribution (x-axis) of 58 primary 
articles published presented in density plot (grey area, left y-axis) and paper count (white bars, right y-axis). 
The gray line indicates theoretical symmetric distribution. Publications were plotted based on published date 
(x-axis), each publication was evaluated on (B) a scale of 0 to 7 (y-axis) for experimental design and 
background, or (C) a scale of 0 to 8 (y-axis) for differentiation and quality control. The number of iPSC lines is 
indicated by the size of the circles, with larger sphere indicating a greater number of iPSC lines. The number of 
patients is indicated by the color of the sphere. A smooth regression line (blue) and a confidence band (grey 
shade) are shown using geom_smooth function through ggplot2 in R. This figure is related to Figures 1-2 in 


















































































Supplemental Table Legends 
 
Supplemental Table S1. Analysis of 58 papers using iPSCs as experimental systems for IDDs.  
Papers were identified using the search terms outlined in this Supplemental Document. All selected papers 
generated patient-derived iPSCs and utilized them to study a particular genetically defined IDD. Column A: List 
of the 58 papers analyzed. Column B & C: Description of the scoring categories and items evaluated from each 
publication. Column D: Minimum score assigned to each publication. Column E: Maximum score assigned to 
each publication.  
 
Supplemental Table S2. Deriving glial cells from iPSCs and their use as experimental systems to model 
IDDs. (A) References describe approaches for deriving glial cell types from iPSCs including astrocytes, 
oligodendrocytes, and microglia. (B) Examples of studies modeling IDDs in iPSC-derived glia are shown. The 
IDD, mutation(s) modeled, glial cell type, and references are indicated.  
 
Supplemental Table S3. Summary of gene editing systems to reduce unwanted genomic modifications 
Table summarizes Cas9 variants that reduce nuclease activity at undesired genomic loci and identifies the 
relevant mutated amino acids in each variant and whether the specific variant modifies the protospacer 
adjacent motif (PAM) binding sequence. Systems that do not introduce a double-strand break (DSB) in the 
DNA are detailed with the protein component responsible for DNA targeting, the protein component 
responsible for DNA modification, and the resultant outcome for each system. 
 
Supplemental Table S4. Directed differentiation into cortical excitatory neurons. 
Technical variables that differ by laboratory and protocol during the specification of human pluripotent cells as 
cortical excitatory neuron progenitors and their differentiation and maturation into glutamatergic excitatory 
neurons were assessed. For neural progenitor specification, these include: (Column B) the signaling cues 
used, (Column C) the basal media used, (Column D) whether differentiation was performed in adherent or 
floating three dimensional embryoid bodies (aEB/EB) or in monolayer culture (ML), (Column E) days of 
specification, and (Column F) the marker expression assessed (green text), with (Column G) indicating the 
percentage of cells expressing the marker indicated in green in Column F. During progenitor differentiation and 
maturation into functional excitatory neurons, similar technical variables were assessed, as were the molecular 
and functional criteria used to assess the neurons generated. Marker indicated in green was used to quantify 
the percentage of excitatory neuron progenitors (Specification Section) or neurons (Differentiation Section) 
obtained, as determined by immunocytochemistry or FACS analysis. Abbreviations and definitions are in 
Supplemental Table S8. 
 
Supplemental Table S5. Directed differentiation into cortical inhibitory interneurons. Technical variables 
that differ by laboratory and protocol were assessed during the specification of human pluripotent stem cells as 
medial ganglionic eminence-like (MGE) interneuron progenitors and their differentiation and maturation into 
GABAergic cortical inhibitory neurons. For MGE progenitor specification, these include: (Column B) the 
signaling cues used, (Column C) treatment with a SHH agonist from initiation of the protocol versus during a 
later time, (Column D) the basal media used, (Column E) specification in monolayers versus in suspended or 
adherent embryoid bodies (ML, EB, aEB), (Column F) days of specification, and (Column G) marker 
expression assessed (green text), with (Column H) indicating the percentage of cells expressing the marker 
shown in green in Column G. During progenitor differentiation and maturation into functional inhibitory neurons, 
similar technical variables were assessed, as were the molecular and functional criteria used to assess the 
neurons generated. Marker indicated in green was used to quantify the percentage of interneuron progenitors 
(Specification Section) or inhibitory neurons (Differentiation Section) obtained, as determined by 
immunocytochemistry or FACS analysis. Functional analysis of the neurons generated is also indicated, if 
performed. In some cases (indicated), a reporter line with GFP knock-in to the NKX2-1 locus was also used to 
enrich for specified progenitors by FACS. Abbreviations and definitions are in Supplemental Table S8.  
 
Supplemental Table S6. NGN2-induced differentiation into cortical excitatory neurons. Technical 
variables that differ by laboratory were assessed by using published NGN2-induced iN protocols. Technical 
variables include: (Column B) transcription factor used, (Column C) starting cell type, (Column D) PSC culture 
conditions prior to differentiation, (Column E) plating density, (Column F) Doxycycline concentration used for 
induction, (Column G) Timing of doxycycline treatment, (Column H) timing for drug selection, (Column I) drug 
selection dosage, (Column J) timing for glial coculture, (Columns K-L) Ara-C use, concentration, and timing, 
and (Columns N-O) basal differentiation media and supplements. Note that one protocol used FACS to enrich 
for the CAMK2-expressing neuronal population (Column M). Also shown are the (Column P) earliest time point 
when neurons could be assayed, (Column Q) the molecular markers assessed, and (Column R) the functional 
assays performed. Abbreviations and definitions are in Supplemental Table S8. 
  
Supplemental Table S7. Recommended reporting table. The table contains the recommendations for 
documentation and characterization at different stages of iPSC culture and differentiation, in a format to be 
completed by the researcher. This table is designed to help researchers track their progress and maintain best 
practices at each stage, with the goals of improving transparency, rigor, and reproducibility. (Y/N stands for 
Yes/No). 
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